15302491

Source:http://linkedlifedata.com/resource/pubmed/id/15302491

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023981, umls-concept:C0205179, umls-concept:C0205267, umls-concept:C0439611, umls-concept:C0684224, umls-concept:C0936223, umls-concept:C1096776, umls-concept:C1515985, umls-concept:C1517927
pubmed:issue	2
pubmed:dateCreated	2004-8-10
pubmed:abstractText	To clarify the effect of intermittent androgen suppression on the time to androgen-independent progression and changes in quality of life (QOL).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0366151
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Androgens, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Flutamide, http://linkedlifedata.com/resource/pubmed/chemical/Gonadotropin-Releasing Hormone, http://linkedlifedata.com/resource/pubmed/chemical/Leuprolide, http://linkedlifedata.com/resource/pubmed/chemical/Neoplasm Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Testosterone, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	1527-9995
pubmed:author	pubmed-author:AkakuraKoichiroK, pubmed-author:Chiba Prostate Study Group, pubmed-author:IsakaShigeoS, pubmed-author:ItoHaruoH, pubmed-author:MasaiMotoyukiM, pubmed-author:NakatsuHiroomiH, pubmed-author:SatoNaohideN, pubmed-author:TanakaMasashiM
pubmed:issnType	Electronic
pubmed:volume	64
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	341-5
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:15302491-Adenocarcinoma, pubmed-meshheading:15302491-Aged, pubmed-meshheading:15302491-Androgens, pubmed-meshheading:15302491-Antineoplastic Agents, Hormonal, pubmed-meshheading:15302491-Disease Progression, pubmed-meshheading:15302491-Drug Administration Schedule, pubmed-meshheading:15302491-Flutamide, pubmed-meshheading:15302491-Follow-Up Studies, pubmed-meshheading:15302491-Gonadotropin-Releasing Hormone, pubmed-meshheading:15302491-Humans, pubmed-meshheading:15302491-Leuprolide, pubmed-meshheading:15302491-Male, pubmed-meshheading:15302491-Neoplasm Proteins, pubmed-meshheading:15302491-Neoplasms, Hormone-Dependent, pubmed-meshheading:15302491-Pilot Projects, pubmed-meshheading:15302491-Prospective Studies, pubmed-meshheading:15302491-Prostate-Specific Antigen, pubmed-meshheading:15302491-Prostatic Neoplasms, pubmed-meshheading:15302491-Quality of Life, pubmed-meshheading:15302491-Questionnaires, pubmed-meshheading:15302491-Testosterone, pubmed-meshheading:15302491-Treatment Failure, pubmed-meshheading:15302491-Tumor Markers, Biological
pubmed:year	2004
pubmed:articleTitle	Intermittent androgen suppression for locally advanced and metastatic prostate cancer: preliminary report of a prospective multicenter study.
pubmed:affiliation	Department of Urology, Ichihara Hospital, Teikyo University School of Medicine, Chiba, Japan.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study